Nanoscale horizonsNanoparticlesLiposomesImmunotherapyAdoptiveHumans
Lipid nanoparticles for engineering next generation CAR T cell immunotherapy.
Melgious Jin Yan Ang, Ann E Metzloff, Ajay S Thatte, Michael J Mitchell
Published: 202610.1039/d5nh00432b
Abstract
Lipid nanoparticles are a burgeoning technology which has vast potential to improve chimeric antigen receptor (CAR) T cell immunotherapy. This focused review provides an overview of CAR T cell therapy - highlighting its promises, limitations, and cha…
Preview only. Read the full abstract at the source